Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Common side effects include fluid retention, nausea, vomiting, myalgia, fatigue,···【more】
Release date：2026-01-09Recommended：31
Capmatinib inhibits c-Met, a type of tyrosine kinase that plays a role in embryo···【more】
Release date：2026-01-09Recommended：32
Capmatinib is a kinase inhibitor indicated for the treatment of adult patients w···【more】
Release date：2026-01-09Recommended：30
Capmatinib is the first therapy approved by the U.S. Food and Drug Administratio···【more】
Release date：2026-01-09Recommended：26
Capmatinib (brand name: Capmatinib) is an anticancer drug indicated for the trea···【more】
Release date：2026-01-09Recommended：29
Capmatinib is indicated for the treatment of lung cancer. Its mechanism of actio···【more】
Release date：2026-01-09Recommended：37
Capmatinib is indicated for the treatment of a specific type of non-small cell l···【more】
Release date：2026-01-09Recommended：84
Capmatinib is an antineoplastic agent (cancer medication). It works by interferi···【more】
Release date：2026-01-09Recommended：27
Capmatinib is indicated for the treatment of metastatic (spread) non-small cell ···【more】
Release date：2026-01-09Recommended：31
On February 11, 2020, Novartis announced that the U.S. Food and Drug Administrat···【more】
Release date：2026-01-09Recommended：29
On May 6, 2020, Novartis announced today that the U.S. Food and Drug Administrat···【more】
Release date：2026-01-09Recommended：28
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unres···【more】
Release date：2026-01-08Recommended：28
